New treatment, Dupilumab, could be used to treat patients with severe asthma

Dupilumab, labelled a “wonder drug”, could be used to help those with severe cases of asthma.

A new treatment for asthma has been given the go-ahead for public use by the National Institute for Health and Care Excellence (NICE). Initial studies indicate that it could be a great help to those who suffer severely from the condition and do not respond well to conventional cures.

Dupilumab can also be used to treat eczema and rhinosinusitis. Furthermore, evidence suggests that Dupilumab can also bring improvements to lung functionality in people who suffer from severe asthma.

While Dupilumab has its uses and considerable upsides, it is also known to cause potential side effects. These include, but are not limited to, headaches, inflammation and strong allergic reactions in some people.